A new report from the Australian Institute of Health and Welfare has found that in order to achieve the high level of performance in advanced medical devices (AMDS) that are required, there needs to be a very high level, and a very large, training programme.
The report was released in Melbourne today, but it’s worth reading the whole thing, which is worth your time if you’re interested in the research.
Here’s what you need to know about the new report: The report finds that the current level of training in AMDS is “low”, and that a good training programme needs to include at least two-thirds of medical device training courses to achieve an AMDS quality of performance of at least 70 per cent.
But the report does say that it is time to think about ways to boost training, especially in the early stages of the device development process.
It says that the AMDS training is not adequate and that training should be “more holistic” and “more aligned with the health needs of the patient”.
It recommends that the National Institute of Pharmaceuticals and Drug Administration (NIPPD) develop training curricula that focus on the development and operation of the AMS in the most effective manner possible, including: “the design and maintenance of medical devices for patients with advanced medical conditions such as Parkinson’s disease and Alzheimer’s disease” “preventive healthcare in conditions such, for example, as post-operative pain” This is good news for the industry, which has been under intense pressure from politicians in the US and elsewhere to increase training, with more than 70 per diems of AMDS equipment costing more than $100 million in the UK alone.
The new report, which was developed in partnership with the Australian National University, was commissioned by the government in 2016, and is funded by the Australian Research Council.
According to the report, in order for training to be effective, training should focus on three key areas: the development and management of the devices; the provision of clinical care to the patient; and the assessment of the effectiveness of training and clinical care.
In the report’s section on medical devices, the authors write that, in a “dynamic clinical setting” there is “the need for the device to be accessible to patients, including people with disabilities, and for the development of appropriate patient-centered clinical care”.
In addition to this, there is a “need to identify and support high-performing clinical teams who are highly trained in the use of the new technology” to provide patient care and, importantly, to “support patient and health-care professionals to meet the complex demands of patients and health care professionals” (emphasis added).
The authors of the report recommend that the Australian Government “make training a key focus of government research”.
“We believe the current levels of training are inadequate, as evidenced by the high rates of AMD in the Australian health care system,” they write.
“In particular, the existing AMDS-related research and development pathway is poorly aligned with Australian medical device development needs.”
The Australian Institute for Health and Purpose has been running a clinical trial of a new drug for Alzheimer’s, which they are hoping to deliver by 2019, and it is expected that it will have a big impact on the AMDP quality of care.
The new report says that there needs “to be a strong and well-supported training programme for AMDS clinical device development”.
Read more here